Rat CD4+CD8+ macrophages kill tumor cells through an NKG2D- and granzyme/perforin-dependent mechanism

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 2999-3006

  Baba, Tomohisa ^a,c   Iwasaki, Sari ^a   Maruoka, Takako ^a   Suzuki, Akira ^a   Tomaru, Utano ^a   Ikeda, Hitoshi ^a   Yoshiki, Takashi ^a   Kasahara, Masanori ^a   Ishizu, Akihiro ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME; GRANZYME B; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; RETINOIC ACID DERIVATIVE; SERINE PROTEINASE INHIBITOR; CD4 ANTIGEN; CD8 ANTIGEN; GROWTH INHIBITOR; IMMUNOGLOBULIN RECEPTOR; LECTIN; LIGAND; NATURAL KILLER CELL ACTIVATING RECEPTORS; NKR P2 PROTEIN, RAT; NKR-P2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CD4+ CD8+ MACROPHAGE; CELL ASSAY; CELL INTERACTION; CELL KILLING; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; IN VITRO STUDY; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; ANIMAL; BIOSYNTHESIS; CELL COMMUNICATION; CELL STRAIN COS1; CERCOPITHECUS; DRUG ANTAGONISM; FISCHER 344 RAT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NATURAL KILLER CELL; PHYSIOLOGY; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL COMMUNICATION; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; GROWTH INHIBITORS; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MACROPHAGES; MICE; PERFORIN; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC;

EID: 49149128643     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.2999     Document Type: Article

References (18)

1. + macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype. Blood 107: 2004-2014.
2. 2+-dependent mechanism. J. Exp. Med. 186: 467-472.
3. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, et al. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12: 207-213.
4. Taieb, J., N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, C. Flament, et al. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12: 214-219.
5. Hirabayash, M., M. Kato, T. Aoto, A. Sekimoto, M. Ueda, I. Miyoshi, N. Kasai, and S. Hochi. 2002. Offspring derived from intracytoplasmic injection of transgenic rat sperm. Transgenic Res. 11: 221-228.
6. Tsuji, T., H. Ikeda, T. Tsuchikawa, K. Kikuchi, T. Baba, A. Ishizu, and T. Yoshiki. 2005. Malignant transformation of thymoma in recipient rats by heterotopic thymus transplantation from HTLV-I transgenic rats. Lab. Invest. 85: 851-861.
7. + rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims. J. Immunol. 175: 2408-2417.
8. Hubert, F. X., C. Voisine, C. Louvet, J. M. Heslan, A. Ouabed, M. Heslan, and R. Josien. 2006. Differential pattern recognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subset. J. Immunol. 177: 1007-1016.
9. Bottino, C., R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, et al. 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198: 557-567.
10. Costello, R. T., C. Fauriat, S. Sivori, E. Marcenaro, and D. Olive. 2004. NK cells: innate immunity against hematological malignancies? Trends Immunol. 25: 328-333.
11. Wajant, H. 2006. CD95L/FasL and TRAIL in tumour surveillance and cancer therapy. Cancer Treat. Res. 130: 141-165.
12. Berke, G. 1995. The CTL's kiss of death. Cell 81: 9-12.
13. Lyubchenko, T. A., G. A. Wurth, and A. Zweifach. 2001. Role of calcium influx in cytotoxic T lymphocyte lytic granule exocytosis during target cell killing. Immunity 15: 847-859.
14. Bruno, A. P., D. Lautier, A. T. d'Orgeix, G. Laurent, and A. Quillet-Mary. 2000. Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin. Blood 96: 1914-1920.
15. Carayannopoulos, L. N., O. V. Naidenko, D. H. Fremont, and W. M. Yokoyama. 2002. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169: 4079-4083.
16. Cerwenka, A., A. B. Bakker, T. McClanahan, J. Wagner, J. Wu, J. H. Phillips, and L. L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721-727.
17. Cerwenka, A., and L. L. Lanier. 2001. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 181: 158-169.
18. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1: 119-126.